NICE recommends olaparib for BRCA-mutated breast cancer treatment - PharmaTimes Groundbreaking approval provides new hope for patients in England and Wales

#precisionmedicine #PARPinhibitor #breastcancer #NICErecommended #olaparib #Lynparza #AstraZeneca #AstraZenecaUK #AstraZenecaOncology #genetictesting #OlympiADclinicaltrail #OlympiADphase3trial #BRCAmutations #TestingforBRCAmutations #NationalGenomicTestDirectory
pharmatimes.com/news/nice-re...